mianserin has been researched along with Restless Legs Syndrome in 11 studies
Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.
Restless Legs Syndrome: A disorder characterized by aching or burning sensations in the lower and rarely the upper extremities that occur prior to sleep or may awaken the patient from sleep.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mirtazapine is known to often provoke restless legs syndrome (RLS)." | 7.74 | Factors potentiating the risk of mirtazapine-associated restless legs syndrome. ( Kim, JM; Kim, SW; Park, KH; Shin, IS; Yoon, JS; Youn, T, 2008) |
| "Restless legs syndrome was observed in three patients receiving mianserin." | 7.67 | Mianserin-induced restless legs syndrome. ( Chae, YL; Choi, BM; Kim, CE; Lee, C; Paik, IH, 1989) |
| "Mirtazapine is known to often provoke restless legs syndrome (RLS)." | 3.74 | Factors potentiating the risk of mirtazapine-associated restless legs syndrome. ( Kim, JM; Kim, SW; Park, KH; Shin, IS; Yoon, JS; Youn, T, 2008) |
| "Six cases of restless legs syndrome in association to mianserin are presented." | 3.69 | Mianserin and restless legs. ( Lauerma, H; Markkula, J, 1997) |
| "Restless legs syndrome was observed in three patients receiving mianserin." | 3.67 | Mianserin-induced restless legs syndrome. ( Chae, YL; Choi, BM; Kim, CE; Lee, C; Paik, IH, 1989) |
| " In 9% of patients, RLS was recorded as a side effect related to the administration of AD." | 1.35 | Restless legs syndrome as side effect of second generation antidepressants. ( Gallwitz, T; Kirch, MH; Messer, T; Rottach, KG; Schaner, BM; Teufel, LM; Zivotofsky, AZ, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 8 (72.73) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Makiguchi, A | 1 |
| Nishida, M | 1 |
| Shioda, K | 1 |
| Suda, S | 1 |
| Nisijima, K | 1 |
| Kato, S | 1 |
| Kim, SW | 1 |
| Shin, IS | 1 |
| Kim, JM | 1 |
| Park, KH | 1 |
| Youn, T | 1 |
| Yoon, JS | 1 |
| Ağargün, MY | 1 |
| Kara, H | 1 |
| Ozbek, H | 1 |
| Tombul, T | 1 |
| Ozer, OA | 1 |
| Teive, HA | 1 |
| de Quadros, A | 1 |
| Barros, FC | 1 |
| Werneck, LC | 1 |
| Pae, CU | 2 |
| Kim, TS | 1 |
| Kim, JJ | 1 |
| Chae, JH | 2 |
| Lee, CU | 1 |
| Lee, SJ | 1 |
| Paik, IH | 2 |
| Lee, C | 2 |
| Chang, CC | 1 |
| Shiah, IS | 1 |
| Chang, HA | 1 |
| Mao, WC | 1 |
| Prospero-Garcia, KA | 1 |
| Torres-Ruiz, A | 1 |
| Ramirez-Bermudez, J | 1 |
| Velazquez-Moctezuma, J | 1 |
| Arana-Lechuga, Y | 1 |
| Teran-Perez, G | 1 |
| Rottach, KG | 1 |
| Schaner, BM | 1 |
| Kirch, MH | 1 |
| Zivotofsky, AZ | 1 |
| Teufel, LM | 1 |
| Gallwitz, T | 1 |
| Messer, T | 1 |
| Markkula, J | 1 |
| Lauerma, H | 1 |
| Bahk, WM | 1 |
| Jun, TY | 1 |
| Kim, KS | 1 |
| Choi, BM | 1 |
| Chae, YL | 1 |
| Kim, CE | 1 |
1 trial available for mianserin and Restless Legs Syndrome
| Article | Year |
|---|---|
Fluoxetine-mirtazapine interaction may induce restless legs syndrome: report of 3 cases from a clinical trial.
Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combinati | 2006 |
10 other studies available for mianserin and Restless Legs Syndrome
| Article | Year |
|---|---|
Mirtazapine-induced restless legs syndrome treated with pramipexole.
Topics: Aged, 80 and over; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Benzothiazoles; Female; H | 2015 |
Factors potentiating the risk of mirtazapine-associated restless legs syndrome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Antidepressive Agents, Tricycl | 2008 |
Restless legs syndrome induced by mirtazapine.
Topics: Antidepressive Agents; Depressive Disorder, Major; Humans; Male; Mianserin; Middle Aged; Mirtazapine | 2002 |
[Worsening of autosomal dominant restless legs syndrome after use of mirtazapine: case report].
Topics: Aged; Antidepressive Agents, Tricyclic; Depression; Female; Genes, Dominant; Humans; Mianserin; Mirt | 2002 |
Re-administration of mirtazapine could overcome previous mirtazapine- associated restless legs syndrome?
Topics: Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Female; Humans; Mianserin; Middle Aged | 2004 |
Does domperidone potentiate mirtazapine-associated restless legs syndrome?
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Domperidone; Dopamine Antagonis | 2006 |
Restless legs syndrome as side effect of second generation antidepressants.
Topics: Acute Disease; Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Depressive Disorder, M | 2008 |
Mianserin and restless legs.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Arm; Female; Humans; Leg; Male; Mianserin; Mi | 1997 |
Mirtazapine may have the propensity for developing a restless legs syndrome? A case report.
Topics: Depressive Disorder; Electroencephalography; Female; Histamine H1 Antagonists; Humans; Mianserin; Mi | 2002 |
Mianserin-induced restless legs syndrome.
Topics: Adult; Depressive Disorder; Female; Humans; Mianserin; Middle Aged; Restless Legs Syndrome | 1989 |